Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap CompaniesGlobeNewsWire • 12/05/23
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive PromotionsGlobeNewsWire • 12/04/23
Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare ConferenceGlobeNewsWire • 11/16/23
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate UpdateGlobeNewsWire • 11/08/23
Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®GlobeNewsWire • 11/02/23
Catalyst Pharmaceuticals: Agamree Approval Selloff A Long-Term Buying OpportunitySeeking Alpha • 10/31/23
Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education ExpoGlobeNewsWire • 10/30/23
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera PharmaceuticalsGlobeNewsWire • 10/26/23
Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023GlobeNewsWire • 10/23/23
Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for FirdapseZacks Investment Research • 10/16/23
Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFloridaGlobeNewsWire • 10/16/23
Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®GlobeNewsWire • 10/13/23
Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare ConferenceGlobeNewsWire • 09/18/23
Santhera Announces Half-Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 09/07/23
Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung CancerGlobeNewsWire • 08/16/23
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy CongressGlobeNewsWire • 08/14/23